CUT&RUN

Histone Methylation Mark Analyses Distinguish Carts Manufactured from Distinct Sources and Uncover Novel Transcription Factors Associated with In Vivo Function of Carts after Infusion into DLBCL Patients That Are Not Identified By RNA-Seq

Chimeric antigen receptor-modified T cell (CART) therapy has heralded a revolution in cancer immunotherapy. Yet, understanding the …

Fiorenza S, Zheng Y , Sarthy J, Sheih A, Kimble E, Kirchmeier D, Janssens D, Phi T, Gauthier J, Hirayama A, Wu Q, Gottardo R, Riddell S, Maloney D, Henikoff S, Turtle C

CUT&RUN and CUT&Tag

This book chapter is part of the Informatics Technology for Cancer Research Education Resource, designed for the Informatics Technology …

Savonen C, Zheng Y , Henikoff S, Ahmad K